Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 15;215(4):559-565.
doi: 10.1093/infdis/jiw600.

HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study

Ema Flores-Díaz  1 , Karen A Sereday  2 , Silvaneide Ferreira  1 , Bradley Sirak  2 , João Simão Sobrinho  1 , Maria Luiza Baggio  1 , Lenice Galan  3 , Roberto C Silva  4 , Eduardo Lazcano-Ponce  5 , Anna R Giuliano  2 , Luisa L Villa  1   6 , Laura Sichero  1 ; HIM Study group
Affiliations

HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study

Ema Flores-Díaz et al. J Infect Dis. .

Abstract

Background: Human papillomavirus type 6 (HPV-6) and HPV-11 are the etiological agents of approximately 90% of genital warts (GWs). The impact of HPV-6 genetic heterogeneity on persistence and progression to GWs remains undetermined.

Methods: HPV Infection in Men (HIM) Study participants who had HPV-6 genital swabs and/or GWs preceded by a viable normal genital swab were analyzed. Variants characterization was performed by polymerase chain reaction sequencing and samples classified within lineages (A, B) and sublineages (B1, B2, B3, B4, B5). Country- and age-specific analyses were conducted for individual variants; odds ratios and 95% confidence intervals for the risk of GWs according to HPV-6 variants were calculated.

Results: B3 variants were most prevalent. HPV-6 variants distribution differed between countries and case status. HPV-6 B1 variants prevalence was increased in GWs and genital swabs of cases compared to controls. There was difference in B1 and B3 variants detection in GW and the preceding genital swab. We observed significant association of HPV-6 B1 variants detection with GW development.

Conclusions: HPV-6 B1 variants are more prevalent in genital swabs that precede GW development, and confer an increased risk for GW. Further research is warranted to understand the possible involvement of B1 variants in the progression to clinically relevant lesions.

Keywords: HIM Study; HPV-6; genital warts; males; prevalence; variability.

PubMed Disclaimer

References

    1. Wolf R, Davidovici B. Treatment of genital warts: facts and controversies. Clin Dermatol 2010; 28:546–8. - PubMed
    1. Steben M, Garland SM. Genital warts. Best Pract Res Clin Obstet Gynaecol 2014; 28:1063–73. - PubMed
    1. Bouvard V, Baan R, Straif K, et al. ; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens—Part B: biological agents. Lancet Oncol 2009; 10:321–2. - PubMed
    1. Bzhalava D, Guan P, Franceschi S, Dillner J, Clifford G. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology 2013; 445:224–31. - PubMed
    1. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6:271–8. - PubMed

MeSH terms